Gemcitabine response prediction in the adjuvant treatment of resected pancreatic ductal adenocarcinoma using an AI histopathology platform

e16295 Background: Adjuvant chemotherapy improves survival following resection of pancreatic ductal adenocarcinoma (PDAC). A modified fluorouracil/irinotecan/oxaliplatin regimen (mFOLFIRINOX) has demonstrated improved disease free survival and overall survival, though gemcitabine-based monotherapy a...

Full description

Bibliographic Details

Published in:	Journal of clinical oncology Vol. 40; no. 16_suppl; p. e16295
Main Authors:	Krishna, Viswesh, Nimgaonkar, Vivek, Tiu, Ekin, Krishna, Vrishab, Bhambhvani, Hriday, Cook, Stephen, Miller, Daniel, Vrabac, Damir, Joshi, Anirudh, Singhi, Aatur D., Hendifar, Andrew Eugene, Rajpurkar, Pranav, Collisson, Eric Andrew
Format:	Journal Article
Language:	English
Published:	01-06-2022
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!